Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Circ Res ; 130(10): 1510-1530, 2022 05 13.
Article in English | MEDLINE | ID: mdl-35430876

ABSTRACT

BACKGROUND: Coronary artery disease is an incurable, life-threatening disease that was once considered primarily a disorder of lipid deposition. Coronary artery disease is now also characterized by chronic inflammation' notable for the buildup of atherosclerotic plaques containing immune cells in various states of activation and differentiation. Understanding how these immune cells contribute to disease progression may lead to the development of novel therapeutic strategies. METHODS: We used single-cell technology and in vitro assays to interrogate the immune microenvironment of human coronary atherosclerotic plaque at different stages of maturity. RESULTS: In addition to macrophages, we found a high proportion of αß T cells in the coronary plaques. Most of these T cells lack high expression of CCR7 and L-selectin, indicating that they are primarily antigen-experienced memory cells. Notably, nearly one-third of these cells express the HLA-DRA surface marker, signifying activation through their TCRs (T-cell receptors). Consistent with this, TCR repertoire analysis confirmed the presence of activated αß T cells (CD4

Subject(s)
Coronary Artery Disease , Plaque, Atherosclerotic , T-Lymphocytes , Antigens , Clone Cells/immunology , Coronary Artery Disease/immunology , Endothelial Cells , Epitopes , HLA-DR alpha-Chains , Humans , Lymphocyte Activation , Plaque, Atherosclerotic/immunology , T-Lymphocytes/immunology
2.
J Immunol Methods ; 453: 37-43, 2018 02.
Article in English | MEDLINE | ID: mdl-29174717

ABSTRACT

For more than five years, high-dimensional mass cytometry has been employed to study immunology. However, these studies have typically been performed in one laboratory on one or few instruments. We present the results of a six-center study using healthy control human peripheral blood mononuclear cells (PBMCs) and commercially available reagents to test the intra-site and inter-site variation of mass cytometers and operators. We used prestained controls generated by the primary center as a reference to compare against samples stained at each individual center. Data were analyzed at the primary center, including investigating the effects of two normalization methods. All six sites performed similarly, with CVs for both Frequency of Parent and median signal intensity (MSI) values<30%. Increased background was seen when using the premixed antibody cocktail aliquots at each site, suggesting that cocktails are best made fresh. Both normalization methods tested performed adequately for normalizing MSI values between centers. Clustering algorithms revealed slight differences between the prestained and the sites-stained samples, due mostly to the increased background of a few antibodies. Therefore, we believe that multicenter mass cytometry assays are feasible.


Subject(s)
Flow Cytometry/methods , Leukocytes, Mononuclear/physiology , Mass Spectrometry/methods , Antibodies/metabolism , Healthy Volunteers , Humans , Immunophenotyping , Pilot Projects , Reference Standards
SELECTION OF CITATIONS
SEARCH DETAIL